COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Intacs for Keratoconus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00347230
Recruitment Status : Unknown
Verified September 2005 by Singapore National Eye Centre.
Recruitment status was:  Recruiting
First Posted : July 4, 2006
Last Update Posted : July 7, 2006
Information provided by:
Singapore National Eye Centre

Brief Summary:
To study the effects Intacs intracorneal ring segments(Addition Technology, Inc) insertion in the treatment of keratoconus

Condition or disease Intervention/treatment Phase
Keratoconus Device: Intacs intracorneal ring insertion for the treatment of keratoconus Not Applicable

Detailed Description:

The purpose of this evaluation is to study the effects of implanting INTACS inserts, identical to those commercially available to correct myopia, into the corneal stroma of patients with keratoconus (mild to moderate) and having a clear cornea. The principle of the procedure is to flatten the cornea deformed by keratoconus. One or two segments of the same or a different thickness will be selected to reduce the asymmetric astigmatism responsible for the patient impaired visual acuity.

The surgical technique is based on locating the INTACS inserts on the flattest axis of the refractive error, making the incision on the steepest axis, using 150 degree arc length inserts with different sizes (0.250, 0.300, 0.350, 0.400 & 0.450 mm) according to a nomogram designed for this technique using the INTACS Instrumentation (10-Step Prolate System instruments).

The corneal lamellar channel creation may be performed using the INTACS instrumentation or using the Femtosecond laser (Femtec 20/10 laser[Femtec,Heidelberg Germany])

Primary Assessment Criteria

  • Evaluation of the safety of the device for the treatment of patients with keratoconus (mild to moderate)
  • Maintenance of best corrected visual acuity (BCVA)
  • Improvement in uncorrected visual acuity (UCVA)
  • Reduction in manifest refraction spherical equivalent
  • Reduction in asymmetric astigmatism

Secondary Assessment Criteria

  • Evaluation of the effect of INTACS inserts placement for treatment of corneal ectasia
  • Determination of patient satisfaction following the INTACS inserts procedure Patients meeting the eligibility criteria are required to sign a Patient Informed Consent Form prior to study participation.

A thorough examination is perform to evaluate the following:

  • Manifest refraction results - Uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA)
  • Cycloplegic refraction results - Uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA)
  • Corneal topography
  • Pachymetry
  • Step axis location
  • Location of incision placement
  • Subjective feedback about quality of vision (Excellent, Good, Fair and Poor)

Post-operative Assessment(at 1 day, 1 week, 1 month and 3 months postop)

  • Uncorrected visual acuity (UCVA) and best corrected visual acuity with manifest refraction(BCVA) at designated time interval
  • Cycloplegic refraction results - Uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA) at designated time interval
  • Corneal topography at designated time interval
  • Pachymetry at designated time interval
  • Subjective visual outcome ratings over time (Excellent, Good, Fair and Poor)
  • Report adverse events

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 20 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Intacs for Keratoconus
Study Start Date : October 2005

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Visual acuity
  2. Refraction
  3. Corneal topography

Secondary Outcome Measures :
  1. Patient satisfaction following procedure

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Patients must have keratoconus (mild to moderate).
  • Visual acuity with contact lenses must be better than or equal to (20/40).
  • Patients must be intolerant of contact lenses, i.e., they must be unable to wear contact lenses for a whole day.
  • Patients will have a corneal thickness of 425 microns at the site of ICRS (INTACS inserts) placement (the thinnest region of the cornea).
  • In terms of general health, patients must not have any illnesses posing an immediate threat to life.
  • Patients must have provided written informed consent at least one week prior to surgery.
  • Patients must over 21 years of age.
  • Patients' contact lenses must have been removed at least one week prior to surgery for soft lenses and two weeks prior to surgery for hard lenses.

Exclusion Criteria:

  • Positive pregnancy test.
  • Breast-feeding.
  • History of previous ophthalmologic surgery on the operative eye.
  • Patients with corneal stromal disorders.
  • Patients with history of herpetic keratitis.
  • Patients with retinal disorders.
  • Corneal grafts.
  • Patients refusing to remove contact lenses one week before surgery for soft lenses and two weeks before surgery for hard lenses.
  • Patients with amblyopia (VA <1110 for the contralateral eye).
  • Patients with corneal thickness <425 microns.
  • Patients with TOP <10 mmHg or >21 mmHg.
  • Patients taking part in other biomedical research in the 30 days prior to the start of this study.
  • Patients with an uncooperative disposition.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00347230

Layout table for location contacts
Contact: Li - Lim, FRCS(Ed) 65-63228896
Contact: Donald TH Tan, FRCS 65-63224500

Layout table for location information
Singapore National Eye Centre Recruiting
Singapore, Singapore, 168751
Sub-Investigator: Li - Lim, FRCS(Ed)         
Sponsors and Collaborators
Singapore National Eye Centre
Layout table for investigator information
Principal Investigator: Donald TH Tan, FRCS Singapore National Eye Centre
Layout table for additonal information Identifier: NCT00347230    
Other Study ID Numbers: R419/14/2005
First Posted: July 4, 2006    Key Record Dates
Last Update Posted: July 7, 2006
Last Verified: September 2005
Keywords provided by Singapore National Eye Centre:
Intacs ring segments
Additional relevant MeSH terms:
Layout table for MeSH terms
Corneal Diseases
Eye Diseases